Investing Profile

Tony Evnin

VCInvestor
Partner at Venrock Associates
Photo of Tony Evnin, Partner at Venrock

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Venrock Partner
$2.0M - $40.0M
$10.0M
22
$450M
CompanyStageDateRound SizeTotal Raised
Constellation Pharmaceuticals
Series FApr 2018$100M
Series EJul 2017$49M
Series EDec 2015$55M
Series BJun 2011$15M
Series BJun 2010$22M
Series AAug 2009$17M
Series AApr 2008$32M
$390M
Co-investors: David Goeddel (The Column Group), Brian Gallagher (Abingworth), Robert Tepper (Third Rock Ventures)
Kallyope
Series ADec 2015$44M
$480M
Co-investors: Josh Wolfe (Lux Capital Management), Tim Kutzkey (The Column Group), Bill Gates
Juno Therapeutics
Series BAug 2014$130M
Series AApr 2014$56M
$310M
Co-investors: Robert Nelsen (ARCH Venture Partners), Bong Koh (Venrock)
Acceleron Pharma
Series UnknownJun 2010$10M
Series COct 2007$31M
Series BAug 2006$30M
$71M
Co-investors: Carl Gordon (OrbiMed), Terry McGuire (Polaris Partners), Jean George (Advanced Technology Ventures)
CymaBay Therapeutics
Series ENov 2009$9M
Series DApr 2007$32M
Series BDec 2004$44M
$190M
Co-investors: Andrew Schwab (5am Ventures), Bali Muralidhar (Abingworth)
AVEO Oncology
Series DMay 2007$53M
Series CMay 2005$5M
Series BOct 2003$43M
Series AMay 2002$15M
$120M
Co-investors: Paul Walker (New Enterprise Associates (NEA)), Blake Wu (New Enterprise Associates (NEA)), Doug Cole (Flagship Ventures)
Idun Pharmaceuticals
Series ADec 2002$23M
$50M
Co-investors: Luke Evnin (MPM Capital), Dion Madsen (Amplitude VC)
Infinity Pharmaceuticals
Series BJun 2002$70M
$170M
Co-investors: James Flynn (Deerfield Management)